Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

438.65 +4.27 (+0.98%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
61 62 Next >
Here's How Much $100 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth Today
Via Benzinga
3 Gene Editing Stocks Shaping the Future of Medicine
Gene editing stocks offer a bold venture into biopharma's future, leveraging CRISPR technology for transformative healthcare solutions 
Via InvestorPlace
2 Historically Flawless Metrics Suggest the Stock Market Can Plunge: Here Are 3 Stocks I've Sold Ahead of What May Be a Big Move for Wall Street
Neither of these predictive indicators has ever been wrong when back-tested for more than 150 years! 
Via The Motley Fool
3 Monster Stocks in the Making to Buy Right Now
They're small now, but these stocks could grow much larger. 
Via The Motley Fool
The 3 Best Neuroscience Biotech Stocks to Buy Now
Given the high bar to developing good neuroscience drugs, firms that do so will likely succeed. Here are three top biotech stocks to buy now. 
Via InvestorPlace
Forecasting The Future: 13 Analyst Projections For Vertex Pharmaceuticals
Via Benzinga
Check Out What Whales Are Doing With VRTX
Via Benzinga
Why the quality investor may take a look at NASDAQ:VRTX.
Examining the Quality Attributes of NASDAQ:VRTX. 
Via Chartmill
Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say following its July meeting. 
Via Benzinga
Topics Economy
Exposures Interest Rates
2 No-Brainer Growth Stocks to Buy With $1,000 Right Now
These companies are paving the way to future growth and market share in their respective industries. 
Via The Motley Fool
Is Vertex Pharmaceuticals' Monopoly in Danger?
As a shareholder, I am nowhere close to panic mode. 
Via The Motley Fool
Why VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) qualifies as a quality stock.
Is VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) suited for quality investing? 
Via Chartmill
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
Vertex shares have soared by triple-digit percentages over the past three years. 
Via The Motley Fool
7 Biotech Stocks to Keep on Your Clinical Radar
Biotech stocks have always been relevant. However, with the latest shift in the political race, this sector is bound to grab more eyeballs. 
Via InvestorPlace
Looking for growth without the hefty price tag? Consider NASDAQ:VRTX.
VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) is not too expensive for the growth it is showing. 
Via Chartmill
3 Gene Editing Stocks That Could Grow Your Wealth
Investors looking for gene editing stocks of cutting edge technology firms should consider these biotech stocks. 
Via InvestorPlace
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
CRISPR Therapeutics could start reporting product revenue soon. 
Via The Motley Fool
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
These innovative drugmakers are hard to ignore. 
Via The Motley Fool
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
Revenue is climbing at these two drug companies -- and the trend should continue. 
Via The Motley Fool
Got $1,000? 2 Incredible Growth Stocks to Buy and Hold Forever
These companies have what it takes to stand the test of time in a portfolio. 
Via The Motley Fool
The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024
Finding undervalued gene editing stocks is easy, but having the patience to stick with them is the challenge. 
Via InvestorPlace
Healthcare Stocks Continue To Lag The Market-Can Anything Help ?
Healthcare stocks continue to lag the market up about 6% YTD, helped by Large Cap Biopharma but hurt by United Health. 
Via Talk Markets
3 No-Brainer Stocks to Buy in July
Investors shouldn't have to think too hard about these great stocks. 
Via The Motley Fool
3 Pharma Stocks Already Ushering in the Next Biotech Boom
So long as diseases afflict the human condition, there will likely always be a need for pharma stocks. Here are three to consider. 
Via InvestorPlace
Prediction: This Will Be Vertex Pharmaceuticals' New Billion-Dollar Growth Driver (and It's Coming Soon).
Vertex shares have advanced by triple digits over the past few years. 
Via The Motley Fool
The 3 Best Biotech Stocks to Buy in July 2024
For investors looking for promising biotech investments should explore the best biotech stocks to watch in July 2024. 
Via InvestorPlace
1 Stock That Increased 10,000% in 33 Years to Buy and Hold Forever
It's not too late to get in on the act. 
Via The Motley Fool
Did Vertex Pharmaceuticals Just Invent the Next Ozempic?
Vertex Pharmaceuticals likely has a breakthrough medicine on its hands. 
Via The Motley Fool
Forget Eli Lilly: 3 Biotech Stocks to Buy Instead
Eli Lilly is a good stock to buy, but these should be even better. 
Via The Motley Fool
3 Top-Rated Gene Editing Stocks Actually Making Money
Profitable gene editing stocks make increasingly compelling investments as therapies commercialize this year and beyond. 
Via InvestorPlace
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
61 62 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.